The role of radical cystectomy in patients with unresectable or regionally metastatic urothelial carcinoma of the bladder

[1]  R. Millikan,et al.  Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. , 2014, The Journal of urology.

[2]  C. Tangen,et al.  Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710 , 2014, Cancer.

[3]  A. Scott,et al.  18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer. , 2014, Urology.

[4]  S. Horenblas,et al.  Impact of 18F‐fluorodeoxyglucose (FDG)‐positron‐emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle , 2013, BJU international.

[5]  C. Dinney,et al.  Management of metastatic urothelial cancer: the role of surgery as an adjunct to chemotherapy. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[6]  H. G. van der Poel,et al.  Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experience. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[8]  S. Kaffenberger,et al.  Surgical and chemotherapeutic management of regional lymph nodes in bladder cancer. , 2012, The Journal of urology.

[9]  J. Witjes,et al.  Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. , 2011, European urology.

[10]  C. Dinney,et al.  The role of radical cystectomy in patients with clinical T4b bladder cancer. , 2011, Urologic oncology.

[11]  O. Akin,et al.  Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Sagalowsky,et al.  Prevention and management of complications following radical cystectomy for bladder cancer. , 2010, European urology.

[13]  A. Siefker-Radtke.  Surgical consolidation of initially unresectable urothelial carcinoma: an incremental opportunity to cure , 2009, Expert review of anticancer therapy.

[14]  W. Meinhardt,et al.  Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  S. Groshen,et al.  Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. , 2007, The Journal of urology.

[16]  J. Schornagel,et al.  Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer. , 2005, The Journal of urology.

[17]  Nicholas J Vogelzang,et al.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. , 2003, The New England journal of medicine.

[18]  C. Vale.  Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis , 2003, The Lancet.

[19]  R. Millikan,et al.  Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder? , 2003, The Journal of urology.

[20]  H. Herr.  Superiority of ratio based lymph node staging for bladder cancer. , 2003, The Journal of urology.

[21]  D. Bajorin,et al.  Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer. , 2001, The Journal of urology.

[22]  S. Groshen,et al.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Mazumdar,et al.  Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J. Bacik,et al.  Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  J. Paradelo,et al.  Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study. , 1997, The Journal of urology.

[26]  R. Wahlqvist,et al.  Five-year Followup of a Prospective Trial of Radical Cystectomy and Neoadjuvant Chemotherapy: Nordic Cystectomy Trial 1 , 1996 .

[27]  C. Dinney,et al.  Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone. , 1995, International journal of radiation oncology, biology, physics.

[28]  C. Dinney,et al.  Preoperative radiotherapy for muscle‐invasive bladder carcinoma. Long term follow‐up and prognostic factors for 338 patients , 1994, Cancer.

[29]  M. Dimopoulos,et al.  Pattern of failure and survival of patients with metastatic urothelial tumors relapsing after cis-platinum-based chemotherapy. , 1994, The Journal of urology.

[30]  H. Grossman,et al.  Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy. , 2009, Urology.

[31]  R. Millikan,et al.  Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. , 2007, Urology.

[32]  W. Fair,et al.  The impact of primary stage on survival in patients with lymph node positive bladder cancer. , 1999, The Journal of urology.

[33]  S. Johansson,et al.  A prospective randomized study of preoperative irradiation with cystectomy or cystectomy alone for invasive bladder carcinoma. , 1983, European urology.